Global Medical REIT Inc (NYSE: GMRE) has seen a decline in its stock price by -2.35 in relation to its previous close of 7.02. However, the company has experienced a -11.32% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-04-08 that Many REITs are offering dividend yields in excess of 10%. But some of them are in very bad shape. I highlight three high yielding REITs to sell asap.
Is It Worth Investing in Global Medical REIT Inc (NYSE: GMRE) Right Now?
The price-to-earnings ratio for Global Medical REIT Inc (NYSE: GMRE) is 576.05x, which is above its average ratio. Moreover, the 36-month beta value for GMRE is 1.32. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for GMRE is 63.10M and currently, short sellers hold a 2.86% of that float. On April 11, 2025, GMRE’s average trading volume was 530.85K shares.
GMRE’s Market Performance
GMRE stock saw a decrease of -11.32% in the past week, with a monthly decline of -20.84% and a quarterly a decrease of -8.84%. The volatility ratio for the week is 8.61%, and the volatility levels for the last 30 days are 3.85% for Global Medical REIT Inc (GMRE). The simple moving average for the last 20 days is -16.29% for GMRE stock, with a simple moving average of -21.88% for the last 200 days.
Analysts’ Opinion of GMRE
Many brokerage firms have already submitted their reports for GMRE stocks, with B. Riley Securities repeating the rating for GMRE by listing it as a “Neutral.” The predicted price for GMRE in the upcoming period, according to B. Riley Securities is $9 based on the research report published on April 03, 2025 of the current year 2025.
Berenberg, on the other hand, stated in their research note that they expect to see GMRE reach a price target of $11.75. The rating they have provided for GMRE stocks is “Buy” according to the report published on October 18th, 2024.
Alliance Global Partners gave a rating of “Buy” to GMRE, setting the target price at $12 in the report published on September 19th of the previous year.
GMRE Trading at -17.59% from the 50-Day Moving Average
After a stumble in the market that brought GMRE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.75% of loss for the given period.
Volatility was left at 3.85%, however, over the last 30 days, the volatility rate increased by 8.61%, as shares sank -21.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.45% lower at present.
During the last 5 trading sessions, GMRE fell by -10.41%, which changed the moving average for the period of 200-days by -21.84% in comparison to the 20-day moving average, which settled at $8.19. In addition, Global Medical REIT Inc saw -11.20% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GMRE
Current profitability levels for the company are sitting at:
- 0.33 for the present operating margin
- 0.73 for the gross margin
The net margin for Global Medical REIT Inc stands at 0.05. The total capital return value is set at 0.08. Equity return is now at value 1.19, with 0.53 for asset returns.
Based on Global Medical REIT Inc (GMRE), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at 0.11. The debt to equity ratio resting at 1.22. The interest coverage ratio of the stock is 1.62.
Currently, EBITDA for the company is 91.47 million with net debt to EBITDA at 6.6. When we switch over and look at the enterprise to sales, we see a ratio of 7.74. The receivables turnover for the company is 18.57for trailing twelve months and the total asset turnover is 0.11.
Conclusion
To wrap up, the performance of Global Medical REIT Inc (GMRE) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
